Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mus musculus

ABSTRACT: Whole Exome Sequencing of breast tumors in a BRCA1 deficient mouse model

PROVIDER: PRJNA380854 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR5428170_1.fastq.gz	Fastqsanger.gz
	SRR5428170_2.fastq.gz	Fastqsanger.gz
	SRR5428169_1.fastq.gz	Fastqsanger.gz
	SRR5428169_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Mus musculus

Project description:Whole-exome sequencing of TET1-deficient tumors

| PRJNA415666 | ENA

The retinoblastoma gene is targeted for rearrangements in BRCA1-deficient basal-like breast cancer.

Project description:Breast tumors from BRCA1 germ line mutation carriers typically exhibit features of the basal-like molecular subtype. However, the specific genes recurrently mutated as a consequence of BRCA1 dysfunction have not been fully elucidated. In this study, we utilized gene expression profiling to molecularly subtype 577 breast tumors, including 73 breast tumors from BRCA1/2 mutation carriers. Focusing on the RB1 locus, we analyzed 33 BRCA1-mutated, 36 BRCA2-mutated and 48 non-BRCA1/2-mutated breast tumors using a custom-designed high-density oligomicroarray covering the RB1 gene. We found a strong association between the basal-like subtype and BRCA1-mutated breast tumors and the luminal B subtype and BRCA2-mutated breast tumors. RB1 was identified as a major target for genomic disruption in tumors arising in BRCA1 mutation carriers and in sporadic tumors with BRCA1 promoter-methylation, but rarely in other breast cancers. Homozygous deletions, intragenic breaks, or microdeletions were found in 33% of BRCA1-mutant tumors, 36% of BRCA1 promoter-methylated basal-like tumors, 13% of non-BRCA1 deficient basal-like tumors, and 3% of BRCA2-mutated tumors. In addition, RB1 was frequently inactivated by gross gene disruption in BRCA1-related hereditary breast cancer and BRCA1-methylated sporadic basal-like breast cancer, but rarely in BRCA2-hereditary breast cancer and non-BRCA1-deficient sporadic breast cancers. Together, our findings demonstrate the existence of genetic heterogeneity within the basal-like breast cancer subtype that is based upon BRCA1-status. Gene expression profiling of breast tumors. Dual color common reference gene expression study using 55K oligonucleotide microarrays.

2012-06-26 | E-GEOD-25307 | biostudies-arrayexpress

The retinoblastoma gene is targeted for rearrangements in BRCA1-deficient basal-like breast cancer.

2012-06-27 | GSE25307 | GEO

Whole exome sequencing suggests much of non BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles.

Project description:Whole exome sequencing identification of putative founder mutations in non-BRCA1/2 breast cancer patients

2013-08-08 | E-MTAB-1172 | biostudies-arrayexpress

Mus musculus

Project description:Molecular profiling of rhabdoid tumors in a Smarcb1-deficient mouse model

| PRJNA368806 | ENA

Mus musculus breed:mus musculus

Project description:Whole exome sequencing of mouse breast cancer cell lines

| PRJNA381678 | ENA

Testis expression in Mus musculus domesticus x Mus musculus musculus hybrid zone mice

Project description:We collected whole genome testis expression data from hybrid zone mice. We integrated GWAS mapping of testis expression traits and low testis weight to gain insight into the genetic basis of hybrid male sterility.

2014-12-04 | GSE61417 | GEO

Mus musculus

Project description:Her2/Neu breast cancer mouse model whole tissue transcriptome

| PRJNA125129 | ENA

Single cell RNA-seq to study heterogeneity and tumorigenesis of Brca1-deficient mouse mammary tumors.

Project description:Brca1 mutation predisposes women to early onset of breast and ovarian cancers.Through its diverse functions in DNA damage repair, cell cycle control, transcription regulation, ubiquitination and so on, BRCA1 acts as a very significant tumor suppressor and genomic safeguard. Brca1 deficiency induces severe cellular stress, when occurring in the mammary glands, it impairs the regular developmental process and eventually causes tumorigenesis due to accumulation of genome instability and other mechanisms. The Brca1-defiencient mouse mammary tumor were characterized with great tumoral heterogeneity, which is in line with the human breast cancers carrying BRCA1 mutations. Here we studied the molecular complexicity of Brca1-deficient mouse mammary tumors vie single cell RNA sequencing.

2021-11-17 | GSE148569 | GEO

Dropseq to study heterogeneity and tumorigenesis of Brca1-deficient mouse mammary tumors.

2021-11-17 | GSE148566 | GEO